Tag: migraine medication and cefaly

A new clinical trial reveals that Cefaly®, the first FDA-approved external trigeminal nerve stimulation device for the prevention of frequent episodic migraines, has been used successfully on migraine patients who do not respond to usual oral migraine medication (refractory migraine). …

Study Finds Migraine Device Cefaly an Effective Treatment for Refractory Migraine Read More »

Tagged with: , , , , , , , , , , ,